TabaÑag, Olivia L.
HRN: 21-23-68 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/14/2022
CEFTRIAXONE 1G (VIAL)
04/14/2022
04/20/2022
IVT
2gm
Every 24hrs
Cap Mr
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes